Breaking News
March 19, 2018 - AcelRx Announces Receipt of Type A FDA Meeting Minutes and Plans to Resubmit the DSUVIA New Drug Application in Q2 2018
March 19, 2018 - Eye Docs Adopt EHRs Despite Reservations
March 19, 2018 - CRISPR enhances cancer immunotherapy
March 19, 2018 - Study finds first evidence of delayed aging among Americans
March 19, 2018 - Essential oils linked to abnormal breast development in boys
March 19, 2018 - ‘Tummy Tuck’ Relieved Postpartum Back Pain/Incontinence
March 19, 2018 - New biomarkers for neuroblastoma, a type of cancer in children
March 19, 2018 - Hookah Smoking Carries a Poisoning Risk
March 19, 2018 - Do Mood and Anxiety Affect MS Disability?
March 19, 2018 - Mean depth of ultrasonographic penetration greater in autism
March 19, 2018 - Platypus milk may help combat antibiotic resistance
March 19, 2018 - U.S. IDE study of THERMOCOOL SMARTTOUCH SF Catheter completes patient enrollment
March 18, 2018 - E-cigarette use exposes adolescents to potentially cancer-causing chemicals
March 18, 2018 - GOP Senator: Solve Opioid Crisis Through Community, Not Policy
March 18, 2018 - Why is ADHD more common in boys than girls?
March 18, 2018 - Measles alert after two passengers with the disease fly into US
March 18, 2018 - FDA looks to remove nicotine from cigarettes
March 18, 2018 - FDA moves to cut nicotine in cigarettes, helping smokers kick habit
March 18, 2018 - Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the Treatment of Actinic Keratosis
March 18, 2018 - Surgery Tied to Better Outcomes in Kids with T2D
March 18, 2018 - Scientists use nanotechnology to detect molecular biomarker for osteoarthritis
March 18, 2018 - Research establishes use of chimeric cells as potential therapy for Duchenne muscular dystrophy
March 18, 2018 - Researcher working to develop improved endoscopic probe for colonoscopies
March 18, 2018 - Researchers develop way to sequence entire fetal genome by modifying prenatal testing method
March 18, 2018 - FDA Approves PDUFA Fee Waiver for Gimoti New Drug Application
March 18, 2018 - P2Y12 Tx Subsidy Yields Positive Response from Docs, Patients
March 18, 2018 - Are Proteins in Formula Linked to Type 1 Diabetes?
March 18, 2018 - Exercise does not seem to increase bone marrow edema in healthy people
March 18, 2018 - Researchers delineate architecture of nuclear pore complex in yeast cells
March 18, 2018 - ‘It’s Just Ghetto-izing People’: What We Heard This Week
March 18, 2018 - Alzheimer’s disease: Neuronal loss very limited
March 18, 2018 - Study reveals impact of intense, changing work schedules experienced by medical interns
March 18, 2018 - Jobs That Keep the Mind Sharp … Even Into Retirement
March 18, 2018 - Facial Scarring Improved with Botulinum Toxin
March 18, 2018 - Data detectives shift suspicions in Alzheimer’s to inside villain
March 18, 2018 - Shorter Preventive TB Tx Effective for HIV+ Patients
March 18, 2018 - New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips
March 18, 2018 - Researchers uncover four microRNAs as potential biomarkers for atrial fibrillation
March 18, 2018 - IRX Therapeutics Announces Initiation of Phase 2 Clinical Trial of IRX-2 in Squamous Cervical or Vulvar Intraepithelial Neoplasia 3
March 18, 2018 - OncoBreak: Learning from Silence; ‘Rigged’ Drug System; NCCN Guidelines Questioned
March 18, 2018 - The coffee cannabis connection
March 18, 2018 - Novel centrifugal-flow pump for heart failure patients provides improved long-term outcomes
March 18, 2018 - U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
March 18, 2018 - Cath Lab Recap: iFR vs FFR $$; Ridaforolimus-Eluting Stent
March 18, 2018 - Tree care workers need better training to handle dangers on the job, study finds
March 18, 2018 - Dementia patients do not undergo diagnostic evaluation at onset of disease, study finds
March 18, 2018 - Transplanting enhanced interneurons restores brain rhythms in mouse model of Alzheimer’s
March 18, 2018 - Gene Therapy Flops for Critical Limb Ischemia
March 17, 2018 - Study spotlights risks in anesthesiologist handoffs
March 17, 2018 - Verb fluency test may be useful tool for differential diagnosis of cognitive failure
March 17, 2018 - Health Tip: Suggestions to Improve Your Cholesterol
March 17, 2018 - Fructans Suspect in Non-Celiac Gluten Sensitivity
March 17, 2018 - Aspirin therapy appears safe before thyroid surgery
March 17, 2018 - Minimally invasive surgical device may one day provide lasting heart repair
March 17, 2018 - UIH and RaySearch enter into new partnership
March 17, 2018 - Is BMI Too Inexact? | Medpage Today
March 17, 2018 - Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms
March 17, 2018 - Leicester research could help identify people with asthma of different severities
March 17, 2018 - Biosense Webster enrolls and treats first AF patient in clinical study of new RF balloon catheter
March 17, 2018 - Participants in rogue herpes vaccine research take legal action
March 17, 2018 - Imara Doses First Patient in Phase 2a Clinical Trial of IMR-687 for Sickle Cell Disease
March 17, 2018 - AAP: Prevent Medication Errors by Improving Processes
March 17, 2018 - Severe sleep apnea during REM sleep tied to acute CV events
March 17, 2018 - Alzheimer’s disease also affects small blood vessels
March 17, 2018 - Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 17, 2018 - Switching Biologics in Psoriasis Care
March 17, 2018 - Polygenic risk score may identify alzheimer’s risk in younger populations
March 17, 2018 - Genetic heart mutations account for fewer sudden and unexplained infant deaths
March 17, 2018 - Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration
March 17, 2018 - Researchers team up to improve life for children with microcephaly
March 17, 2018 - Health guide for young women regarding labiaplasty
March 17, 2018 - Inhaled Nitrite Flops as HFpEF Therapy
March 17, 2018 - California mental health tax providing services to needy in L.A. County, study finds
March 17, 2018 - Cancer survivors become fatigued more quickly than their peers, study finds
March 17, 2018 - Study finds common presence of nightmares among U.S. military personnel
March 17, 2018 - Yellow fever outbreak in Brazil necessitates vaccination for travelers
March 17, 2018 - Health Tip: Waist Size May Help Predict Heart Attack
March 17, 2018 - Low-Dose Combo Pill Successfully Takes Down High BP
March 17, 2018 - Most children with sickle cell anemia not receiving key medication to stay healthy
March 17, 2018 - YCC launches new Yale Center for Immuno-Oncology
Meningitis vaccination strategy in Africa found to be effective, economical

Meningitis vaccination strategy in Africa found to be effective, economical

image_pdfDownload PDFimage_print
Meningitis vaccination strategy in Africa found to be effective, economical
Alternative Vaccination Strategy for Meningitis in Africa. Credit: Yale University

In sub-Saharan Africa, meningococcal meningitis continues to pose a serious health threat, with sporadic epidemics resulting in some 30,000 cases each year. While all people are susceptible, young children are at the highest risk, and over 50 percent of those infected will die if not diagnosed and treated.

An international team of scientists led by Reza Yaesoubi, Ph.D., assistant professor at the Yale School of Public Health, created a novel mathematical model of meningococcal epidemics in Burkina Faso that allowed them to compare several different meningococcal vaccination strategies in terms of their estimated costs and expected health outcomes.

The model revealed that the introduction of newer polyvalent conjugate vaccines into the routine immunization schedule—in combination with a catch-up campaign during which children and young adults were also given the polyvalent conjugate vaccine—was both cost-effective and potentially cost-saving compared to the current public health strategy that uses the meningococcal serogroup A conjugate vaccine for routine immunization of children and polysaccharide vaccines during outbreaks.

These results suggest that new strategies which incorporate polyvalent conjugate vaccines can have substantial health benefits over current practice in Burkina Faso and elsewhere in Africa’s “meningitis belt,” which stretches across the center of the continent. The findings are published in the journal PLOS Medicine.

“Our findings suggest that instead of waiting for the next meningococcal epidemic to occur, start the immunization of impacted districts, it is more cost-effective, and potentially cost-saving, to immunize children and young adults though a nationwide catch-up vaccination campaign,” said Yaesoubi, the study’s lead author. “The population immunity against the meningococcal disease could then be maintained for years by immunizing babies before they turn 1 year old through the routine immunization program.”

Since the late 1970s, control of meningitis epidemics has relied on the use of polysaccharide vaccines to blunt the magnitude of these outbreaks after they have started. This reactive vaccination approach is limited as its effectiveness requires a very rapid scale of a vaccine campaign after recognition of an outbreak, and the polysaccharide vaccines used are not protective for infants under 2 years old and do not induce long-term protection.

More recently, conjugate vaccines which can be used in younger children and offer longer term immunity have been developed and been successfully used in routine vaccination programs to prevent the occurrence of meningococcal outbreaks. The introduction of a meningococcal serogroup A conjugate vaccine into routine immunization programs has been associated with a massive decline in serogroup A associated disease. However, other meningococcal serogroups still circulate widely in the region, and the continuing threat of sporadic epidemics require maintenance of capacity for reactive vaccination campaigns.

The development of newer polyvalent conjugate meningococcal vaccines effective against nearly all circulating serogroups offers the promise of more effective prevention of meningococcal epidemics in this region. This study offers insight on the best way to use these novel polyvalent conjugate vaccines to control meningococcal epidemics in Burkina Faso.

Explore further:
Recommendations updated for meningococcal vaccine in HIV

More information:
Reza Yaesoubi et al. The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study, PLOS Medicine (2018). DOI: 10.1371/journal.pmed.1002495

Journal reference:
PLoS Medicine

Provided by:
Yale University

Tagged with:

About author

Related Articles